SEC Form 4 · Insider disclosures

Insider Trading Tracker

Who bought, who sold, and the disclosed plans and ownership context behind recent SEC Form 4 filings.

Updates are delayed; the last verified disclosures remain available.

Purchase rows312
Sale rows1,613
Purchase value (USD)US$469.72M
Sale value (USD)US$1.44B

Last 10 days of filings·Updated Oct 23, 3:53 AM ET

Recent company disclosures

429 companies · 1,925 rows
BOLD

Boundless Bio, Inc.

Total value ≈ US$349.59K

4 transaction rows · 1 filings

TANG KEVIN / TANG CAPITAL MANAGEMENT LLC

Purchase
10% owner disclosed purchase of 118,185 shares

Filing did not check the 10b5-1 plan indicator

Approximately 2.96M shares in indirect holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$276.55K

TANG KEVIN / TANG CAPITAL MANAGEMENT LLC

Purchase
10% owner disclosed purchase of 12,790 shares

Filing did not check the 10b5-1 plan indicator

Approximately 2.97M shares in indirect holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$29.93K
Show 2 more transaction rows

TANG KEVIN / TANG CAPITAL MANAGEMENT LLC

Purchase
10% owner disclosed purchase of 18,279 shares

Filing did not check the 10b5-1 plan indicator

Approximately 2.99M shares in indirect holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$42.59K

TANG KEVIN / TANG CAPITAL MANAGEMENT LLC

Purchase
10% owner disclosed purchase of 220 shares

Filing did not check the 10b5-1 plan indicator

Approximately 2.99M shares in indirect holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$521.4
BBWI

Bath & Body Works, Inc.

Total value ≈ US$14.23

1 transaction rows · 1 filings

Nash Sarah E

Sale
Director disclosed sale of 0.692 shares

Filing did not check the 10b5-1 plan indicator

Sale represented approximately <0.01% of prior direct holdings; approximately 299K shares remain

Calculated transaction value approximately US$14.23
BCDA

BioCardia, Inc.

Total value ≈ US$475

2 transaction rows · 1 filings

Altman Peter

Purchase
CEO / Director disclosed purchase of 200 shares

Filing did not check the 10b5-1 plan indicator

Approximately 385K shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$190

Altman Peter

Purchase
CEO / Director disclosed purchase of 300 shares

Filing did not check the 10b5-1 plan indicator

Approximately 385K shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$285
JCTC

JEWETT CAMERON TRADING CO LTD

Total value ≈ US$34.69K

6 transaction rows · 3 filings

AJB Investment Fund II, LP / AJB Capital, LLC / Bradley Adam James / Bradley Melinda Hodges

Purchase
10% owner disclosed purchase of 2,136 shares

Filing did not check the 10b5-1 plan indicator

Approximately 539K shares in indirect holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$6.21K

AJB Investment Fund II, LP / AJB Capital, LLC / Bradley Adam James / Bradley Melinda Hodges

Purchase
10% owner disclosed purchase of 1,224 shares

Filing did not check the 10b5-1 plan indicator

Approximately 540K shares in indirect holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$3.56K
Show 4 more transaction rows

AJB Investment Fund II, LP / AJB Capital, LLC / Bradley Adam James / Bradley Melinda Hodges

Purchase
10% owner disclosed purchase of 3,945 shares

Filing did not check the 10b5-1 plan indicator

Approximately 544K shares in indirect holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$11.46K

AJB Investment Fund II, LP / AJB Capital, LLC / Bradley Adam James / Bradley Melinda Hodges

Purchase · 4/A
10% owner disclosed purchase of 883 shares

Filing did not check the 10b5-1 plan indicator

Approximately 533K shares in indirect holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$2.57K

AJB Investment Fund II, LP / AJB Capital, LLC / Bradley Adam James / Bradley Melinda Hodges

Purchase
10% owner disclosed purchase of 973 shares

Filing did not check the 10b5-1 plan indicator

Approximately 534K shares in indirect holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$2.83K

AJB Investment Fund II, LP / AJB Capital, LLC / Bradley Adam James / Bradley Melinda Hodges

Purchase
10% owner disclosed purchase of 2,782 shares

Filing did not check the 10b5-1 plan indicator

Approximately 536K shares in indirect holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$8.08K
CRSP

CRISPR Therapeutics AG

Total value ≈ US$3.35M

4 transaction rows · 4 filings

Kulkarni Samarth

Sale
CEO / Director disclosed sale of 47,837 shares

Filing did not check the 10b5-1 plan indicator

Approximately 312K shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$2.38M

George Simeon

Sale
Director disclosed sale of 14,514 shares

Filing includes a 10b5-1 plan; attribution to this row is unconfirmed

Approximately 15.5K shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$720.37K
Show 2 more transaction rows

KASINGER JAMES R.

Sale
Officer disclosed sale of 1,040 shares

Filing did not check the 10b5-1 plan indicator

Approximately 95.9K shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$51.23K

Kulkarni Samarth

Sale
CEO / Director disclosed sale of 4,098 shares

Filing did not check the 10b5-1 plan indicator

Approximately 260K shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$201.87K
INM

InMed Pharmaceuticals Inc.

Total value ≈ US$14.15K

5 transaction rows · 2 filings

ADAR1 Capital Management, LLC / Schneeberger Daniel

Purchase
10% owner disclosed purchase of 1 shares

Filing did not check the 10b5-1 plan indicator

Approximately 955K shares in indirect holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$1.32

ADAR1 Capital Management, LLC / Schneeberger Daniel

Purchase
10% owner disclosed purchase of 1,086 shares

Filing did not check the 10b5-1 plan indicator

Approximately 957K shares in indirect holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$1.43K
Show 3 more transaction rows

ADAR1 Capital Management, LLC / Schneeberger Daniel

Purchase
10% owner disclosed purchase of 564 shares

Filing did not check the 10b5-1 plan indicator

Approximately 946K shares in indirect holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$750.12

ADAR1 Capital Management, LLC / Schneeberger Daniel

Purchase
10% owner disclosed purchase of 8,021 shares

Filing did not check the 10b5-1 plan indicator

Approximately 955K shares in indirect holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$10.67K

ADAR1 Capital Management, LLC / Schneeberger Daniel

Purchase
10% owner disclosed purchase of 984 shares

Filing did not check the 10b5-1 plan indicator

Approximately 955K shares in indirect holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$1.3K
BRCC

BRC Inc.

Total value ≈ US$254.5K

5 transaction rows · 2 filings

Hafer Evan / EKNRH Holdings LLC

Sale
Officer / Director / 10% owner disclosed sale of 2,724 shares

Filing includes a 10b5-1 plan; attribution to this row is unconfirmed

Approximately 0 shares in indirect holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$28.77K

Hafer Evan / EKNRH Holdings LLC

Sale
Officer / Director / 10% owner disclosed sale of 5,572 shares

Filing includes a 10b5-1 plan; attribution to this row is unconfirmed

Approximately 0 shares in indirect holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$59K
Show 3 more transaction rows

Hafer Evan / EKNRH Holdings LLC

Sale
Officer / Director / 10% owner disclosed sale of 200 shares

Filing includes a 10b5-1 plan; attribution to this row is unconfirmed

Approximately 0 shares in indirect holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$2.1K

Hafer Evan / EKNRH Holdings LLC

Sale
Officer / Director / 10% owner disclosed sale of 200 shares

Filing includes a 10b5-1 plan; attribution to this row is unconfirmed

Approximately 0 shares in indirect holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$2.1K

Hafer Evan / EKNRH Holdings LLC

Sale
Officer / Director / 10% owner disclosed sale of 15,304 shares

Filing includes a 10b5-1 plan; attribution to this row is unconfirmed

Approximately 0 shares in indirect holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$162.53K
VG

Venture Global, Inc.

Total value ≈ US$12.94M

4 transaction rows · 2 filings

Thayer Jonathan W

Sale
CFO disclosed sale of 111,111 shares

Filing includes a 10b5-1 plan; attribution to this row is unconfirmed

Approximately 0 shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$1.41M

Thayer Jonathan W

Sale
CFO disclosed sale of 111,111 shares

Filing includes a 10b5-1 plan; attribution to this row is unconfirmed

Approximately 0 shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$1.41M
Show 2 more transaction rows

Larson Keith D

Sale
Officer disclosed sale of 394,978 shares

Filing includes a 10b5-1 plan; attribution to this row is unconfirmed

Approximately 0 shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$5.28M

Larson Keith D

Sale
Officer disclosed sale of 389,679 shares

Filing includes a 10b5-1 plan; attribution to this row is unconfirmed

Approximately 5.3K shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$4.84M
SWMR

Swarmer, Inc

Total value ≈ US$124.16K

1 transaction rows · 1 filings

Fink Alexander

Sale
Officer / Director disclosed sale of 12,580 shares

Filing did not check the 10b5-1 plan indicator

Sale represented approximately 0.46% of prior direct holdings; approximately 2.68M shares remain

Calculated transaction value approximately US$124.16K
NZF

Nuveen Municipal Credit Income Fund

Total value ≈ US$17.7M

2 transaction rows · 2 filings

Robert Young L

Sale
Reporting owner disclosed sale of 16,131 shares

Filing did not check the 10b5-1 plan indicator

Sale represented approximately 100.00% of prior direct holdings; approximately 0 shares remain

Calculated transaction value approximately US$17.63M

TOTH TERENCE J

Sale
Reporting owner disclosed sale of 6,677 shares

Filing did not check the 10b5-1 plan indicator

Sale represented approximately 100.00% of prior direct holdings; approximately 0 shares remain

Calculated transaction value approximately US$71.81K
NAD

Nuveen Quality Municipal Income Fund

Total value ≈ US$409.54K

5 transaction rows · 2 filings

Robert Young L

Sale
Reporting owner disclosed sale of 32,727 shares

Filing did not check the 10b5-1 plan indicator

Sale represented approximately 100.00% of prior direct holdings; approximately 0 shares remain

Calculated transaction value approximately US$337.74K

TOTH TERENCE J

Purchase
Reporting owner disclosed purchase of 4,587 shares

Filing did not check the 10b5-1 plan indicator

Approximately 8.72K shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$46.47K
Show 3 more transaction rows

TOTH TERENCE J

Purchase
Reporting owner disclosed purchase of 2,500 shares

Filing did not check the 10b5-1 plan indicator

Approximately 11.2K shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$25.3K

TOTH TERENCE J

Purchase
Reporting owner disclosed purchase of 3 shares

Filing did not check the 10b5-1 plan indicator

Approximately 11.2K shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$30.39

TOTH TERENCE J

Purchase
Reporting owner disclosed purchase of 0.3711 shares

Filing did not check the 10b5-1 plan indicator

Approximately 11.2K shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$3.76
JGH

Nuveen Global High Income Fund

Total value ≈ US$233.34K

1 transaction rows · 1 filings

Robert Young L

Sale
Reporting owner disclosed sale of 20,595 shares

Filing did not check the 10b5-1 plan indicator

Sale represented approximately 100.00% of prior direct holdings; approximately 0 shares remain

Calculated transaction value approximately US$233.34K
Sources, coverage & updates
SEC filing dates: 2026-10-14 — 2026-10-23 (America/New_York)

Current-day data is provisional; historical dates are reconciled to official daily indexes.

Last successful sync: Oct 23, 3:53 AM ET

Historical dates reconciled; current day provisional

Discovered filings 2,284 · Parsed 2,284 · Pending 0

Table I non-derivative P/S only. Values use reported price × shares; 9 unavailable, unverified or non-USD amounts are excluded. 743 filings · 691 distinct reporting owners, not necessarily independent decision-makers.

Company grouping is a reading aid, not a merger of transactions or uncertain ownership ratios. Value sorting uses each company’s usable total; expand to see every matching row.

Reading these disclosures

Form 4 disclosures are not real-time trade alerts. An unchecked 10b5-1 indicator does not establish discretionary timing. Direct and indirect holdings remain separate; unresolved amendments stay under review.

Filed prices are not all independently market-verified. Source: SEC EDGAR; the update target is every 15 minutes. Actual freshness is shown by the last successful synchronization.

SEC transaction codes ↗